Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using non-invasive nerve stimulation to improve language recovery in stroke survivors with aphasia

Official title: Transcutaneous Vagus Nerve Stimulation for Language Recovery After Stroke: a Pilot Study

Run by Sheffield Teaching Hospitals NHS Foundation Trust · NCT06403475 · Data updated 2026-11-12

This study is testing if a new non-invasive treatment using nerve stimulation can help stroke survivors with long-term language difficulties improve their communication skills when combined with speech therapy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorSheffield Teaching Hospitals NHS Foundation Trust
Academic / other
Locations1 site (Sheffield)
StatusRecruiting
StartedApril 25, 2024
Main results expectedJune 3, 2026
Study endsJanuary 1, 2027
Registry record updatedDecember 8, 2025
Trial IDNCT06403475 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who have experienced a supratentorial stroke at least six months prior and have aphasia characterized by word-finding difficulties.

Probably not a fit

Patients with implanted devices, currently receiving SLT, or those with severe cognitive or sensory impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the feasibility, safety, and tolerability of Transcutaneous Vagus Nerve Stimulation (tVNS) in individuals with chronic aphasia following a stroke. tVNS is a non-invasive technique that stimulates a branch of the vagus nerve through the skin of the ear, potentially aiding language recovery when combined with computer-based Speech and Language Therapy (SLT). The study aims to assess whether this approach can enhance communication abilities in stroke survivors who have experienced aphasia for more than six months. The findings may support the development of larger randomized controlled trials in the future.

Why it matters

Potential benefit: If successful, this approach could significantly improve language recovery and communication abilities in stroke survivors with chronic aphasia.

How similar studies have gone: While there are no published studies specifically on tVNS for chronic aphasia, there is promising evidence of its benefits in chronic stroke rehabilitation when paired with other therapies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Supratentorial stroke at least 6 months prior to recruitment
* Aphasia (with word finding difficulties)
* Ability to engage in the programme (support can be provided for cognitive or receptive difficulties)
* Sufficient vision to engage in the computer-based SLT programme

Exclusion Criteria:

* Implanted devices (e.g. pacemaker) or implanted stimulation devices
* Currently receiving a programme of Speech and Language Therapy (SLT)
* Damage to the vagus nerve
* Symptomatic bradycardia/ 2nd or 3rd heart block
* Pregnancy
* Unable to speak English
* Severe deafness (despite using hear aids)

Where it's running

  • Sheffield Teaching Hospitals NHS Foundation Trust
    Sheffield, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Dr Ali Ali — Sheffield Teaching Hospitals NHS Foundation Trust
  • Study coordinator: Dr Ali Ali
  • Email: ali.ali@sheffield.ac.uk
  • Phone: 01142159114

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.